GLOBAL STABILITY OF HIV-1 AND HIV-2 MODEL WITH DRUG RESISTANCE COMPARTMENT

被引:5
作者
Amine, Saida [1 ]
Farah, El Mehdi [1 ]
机构
[1] Hassan II Univ Casablanca, Fac Sci & Tech, Dept Math & Comp Sci, Lab Math Comp Sci & Applicat LMCSA, POB 146, Mohammadia 20650, Morocco
关键词
HIV-1; HIV-2; drug therapy; basic reproduction number; stability; sensitivity analysis; HIV/AIDS; INFECTION; DYNAMICS;
D O I
10.28919/cmbn/5643
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
In this paper we propose a new mathematical model describing the dynamics of the human immunodeficiency virus 1 and 2 with drug resistant compartment. We proved the positivity and boundedness of solutions with non-negative initial conditions. The dynamical system admits four equilibrium states: free equilibrium disease, one endemic equilibrium of each strain and one of the two strains. Two basic reproduction numbers are calculated. The global stability of the four equilibrium points is proved by using suitable Lyapunov functions. Numerical simulations were carried out to illustrate our results and a parameter sensitivity analysis completed this work.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] HIV-2可以抑制HIV-1的复制
    孔朝霞
    中国艾滋病性病, 2001, (06) : 357 - 357
  • [42] Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections
    Shanmugam, V
    Switzer, WM
    Nkengasong, JN
    García-Lerma, G
    Green, TA
    Ekpini, E
    Sassan-Morokro, M
    Antunes, F
    Manshino, K
    Soriano, V
    Wiktor, SZ
    Heneine, W
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (03) : 257 - 263
  • [43] Global stability of a delayed HIV-1 infection model with absorption and CTL immune response
    Tian, Xiaohong
    Xu, Rui
    IMA JOURNAL OF APPLIED MATHEMATICS, 2014, 79 (02) : 347 - 359
  • [44] Evaluation of Geenius HIV-1/2 Confirmatory Assay for the confirmatory and differential diagnosis of HIV-1/HIV-2 in Japan and reliability of the Geenius Reader in the diagnosis of HIV-2
    Kusagawa, Shigeru
    Kawana-Tachikawa, Ai
    Matsubayashi, Keiji
    Hoshi, Yuji
    Ishimaru, Ken
    Hamaguchi, Isao
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [45] Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants
    Smith, Robert A.
    Raugi, Dana N.
    Wu, Vincent H.
    Zavala, Christopher G.
    Song, Jennifer
    Diallo, Khardiata Mbaye
    Seydi, Moussa
    Gottlieb, Geoffrey S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [46] HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation
    de Silva, Thushan I.
    Leligdowicz, Aleksandra
    Carlson, Jonathan
    Garcia-Knight, Miguel
    Onyango, Clayton
    Miller, Nicholas
    Yindom, Louis-Marie
    Hue, Stephane
    Jaye, Assan
    Dong, Tao
    Cotten, Matthew
    Rowland-Jones, Sarah L.
    AIDS, 2018, 32 (06) : 709 - 714
  • [47] The HIV-2 OGH double reporter virus shows that HIV-2 is less cytotoxic and less sensitive to reactivation from latency than HIV-1 in cell culture
    Bruggemans, Anne
    Vansant, Gerlinde
    Van de Velde, Paulien
    Debyser, Zeger
    JOURNAL OF VIRUS ERADICATION, 2023, 9 (03)
  • [48] Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study
    Ekouevi, Didier K.
    Balestre, Eric
    Coffie, Patrick A.
    Minta, Daouda
    Messou, Eugene
    Sawadogo, Adrien
    Minga, Albert
    Sow, Papa Salif
    Bissagnene, Emmanuel
    Eholie, Serge P.
    Gottlieb, Geoffrey S.
    Dabis, Francois
    PLOS ONE, 2013, 8 (06):
  • [49] Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?
    da Silva, Zacarias J.
    Oliveira, Ines
    Andersen, Andreas
    Dias, Francisco
    Rodrigues, Amabelia
    Holmgren, Birgitta
    Andersson, Soren
    Aaby, Peter
    AIDS, 2008, 22 (10) : 1195 - 1202
  • [50] An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?
    Hodges-Mameletzis, Ioannis
    De Bree, G. J.
    Rowland-Jones, Sarah L.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (02) : 195 - 206